© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
February 27, 2021
The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.
February 16, 2021
Novartis’ sacubitril/valsartan (Entresto) is now indicated for use in the treatment of chronic heart failure.
February 12, 2021
Belantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies.
January 22, 2021
Officials with the FDA have approved cabotegravir and rilpivirine, injectable formulation (Cabenuva; ViiV Healthcare) as a complete regimen for the treatment of HIV-1 infection in adults.
January 14, 2021
On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).
January 01, 2021
The market for acute lymphocytic leukemia and bladder cancer drug therapies is expected to soar over the next few years, thanks in part to new and innovative medications.
December 31, 2020
Here are some of the top-read FDA approvals covered by Drug Topics® from this year.
December 21, 2020
Acetaminophen injection, 1000 mg/100 mL, is an FDA-approved generic to Ofirmev.
December 04, 2020
The FDA approved azacitidine tablets (Onureg; Celgene Corporation) on September 1, 2020
December 01, 2020
Omalizumab (Xolair; Genentech and Novartis) is the first biologic approved for the treatment of nasal polyps that targets and blocks immunoglobulin E.